Skip to content

What Have Slow Progressors Taught Us About T1D—Mind the Gap!

Research output: Contribution to journalReview article

Original languageEnglish
Article number99
Number of pages8
JournalCurrent diabetes reports
Volume19
DOIs
DateAccepted/In press - 10 Sep 2019
DatePublished (current) - 1 Oct 2019

Abstract

Purpose of Review: Progression rate from islet autoimmunity to clinical diabetes is unpredictable. In this review, we focus on an intriguing group of slow progressors who have high-risk islet autoantibody profiles but some remain diabetes free for decades. Recent Findings: Birth cohort studies show that islet autoimmunity presents early in life and approximately 70% of individuals with multiple islet autoantibodies develop clinical symptoms of diabetes within 10 years. Some “at risk” individuals however progress very slowly. Recent genetic studies confirm that approximately half of type 1 diabetes (T1D) is diagnosed in adulthood. This creates a conundrum; slow progressors cannot account for the number of cases diagnosed in the adult population. Summary: There is a large “gap” in our understanding of the pathogenesis of adult onset T1D and a need for longitudinal studies to determine whether there are “at risk” adults in the general population; some of whom are rapid and some slow adult progressors.

    Research areas

  • Adult onset, Islet autoantibodies, Slow progression, Type 1 diabetes (T1D)

Download statistics

No data available

Documents

Documents

  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via Springer at https://link.springer.com/article/10.1007/s11892-019-1219-1#aboutcontent . Please refer to any applicable terms of use of the publisher.

    Final published version, 932 KB, PDF document

    Licence: CC BY

DOI

View research connections

Related faculties, schools or groups